Insmed's Meteoric Rise: A Cautionary Tale for Fashion Brands?
The fashion industry often looks to other sectors for inspiration, and biotech companies like Insmed are currently experiencing a similar phenomenon a meteoric rise in value.
On Thursday, the company's stock price surged by 33. 86% to $132. 55 per share after nearly quadrupling its revenues in the second quarter of the year.